Skip to main content

Acology Inc. (OTC:ACOL) Releases Big Updates with a Letter to Shareholders from CEO Curt Fairbrother: May 21, 2018

The most recent 10Q highlighted both increased profitability and the expansion that we have undertaken in preparation for the acceleration of events that we firmly believe will propel our company to an extremely strong position in the medical and recreational cannabis industry.

Rochester, NY -- (ReleaseWire) -- 05/22/2018 -- Acology Inc. (OTCMARKETS:ACOL) May 2018 Letter To Shareholders:

Dear Shareholders: Many of you have been following our company since its inception in 2013 and have seen the steady growth that we have achieved in that time. Our most recent 10Q highlighted both increased profitability and the expansion that we have undertaken in preparation for the acceleration of events that we firmly believe will propel our company to an extremely strong position in the medical and recreational cannabis industry. A few of the remarkable achievements that Acology (OTCMARKETS:ACOL) has attained in the first quarter of this year include equipment and infrastructure purchases in preparation of increased sales orders, the acquisition of the ENTIRE intellectual property portfolio for our signature product, the MedTainerâ„¢, the strengthening of our business relationships in Canada and the Canadian LPs, the expansion of business here in our native California and the expansion of our own, branded product lines that now account for almost 40% of our total sales. With these successes has come the certain knowledge that Acology is prepared to take full advantage of the continually escalating cannabis market worldwide.

Several of you in recent weeks have come to our offices to see for yourselves the work that we are doing. In each case you have expressed to us how impressed you were with our operations, the quality of our team and our commitment to continuing our push to position ourselves as the preferred retail packaging solution in the global cannabis industry. Some of you have expressed impatience with the pace of our growth and with our philosophy of growing Acology 'from the inside-out'. I want to assure you here and now that our plan has always been to satisfy both the industry and our shareholders with superior products and services, spectacular customer service, sustained international growth and anticipating and taking advantage of the opportunities that the market has presented and will continue to present to us. I share your annoyance at the pace of the market, especially since we are a 'bricks and mortar' company that deals with packaging. In many cases the legislation that governs packaging rules is either non-existent, evolving or inconclusive. I want to assure you that the MedTainer is at the very top of compliance and function. In short, we are positioned extremely well to take advantage of events that will surely unfold as the year progresses.

I want to take this opportunity to thank you for the advice, criticism, encouragement and constancy that you have given to us over the past 5 years. As the year progresses we will continue to take advantage of our hard-fought position and realize our fantastic potential. Thank you for being with us as we propel ourselves into what I believe will be a fantastic future.

Sincerely,

Curt Fairbrother, CEO

Acology Inc.

For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.

Acology trades on the OTC under the call letters ACOL. The company's websites are http://www.Acologyinc.com for the hospice and palliative care industry and http://www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to info@acologyinc.com or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc

This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company's current expectations. Forward-looking statements are identified by such words as "anticipates", "projects", "expects", "planned", "intends", and "believes", "estimate", "targets", and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all of his or her investment.

Disclaimer:
This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: Investor News Source and its employees are not a Registered Investment Advisors, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Everything you see is a paid advertisement and should not be considered financial advice or a solicitation to buy or sell stock. Always contact the financial institution and do your own research before buying any security which is at your own risk. Investor News Source is a digital marketing company located in Rochester New York.

For more information on this press release visit: http://www.releasewire.com/press-releases/acology-inc-otcacol-releases-big-updates-letter-shareholders-982110.htm

Media Relations Contact

Derek C McCarthy
Editor
Investor News Source
Email: Click to Email Derek C McCarthy
Web: https://www.facebook.com/Investornewssrc

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.